Skip to main content
Clinical Trials/NCT01369459
NCT01369459
Completed
Phase 1

Family-Based Protocol for Medication Integration in Treatment of Comorbid ASU/ADHD

The National Center on Addiction and Substance Abuse at Columbia University1 site in 1 country14 target enrollmentNovember 2011

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Attention Deficit Hyperactivity Disorder
Sponsor
The National Center on Addiction and Substance Abuse at Columbia University
Enrollment
14
Locations
1
Primary Endpoint
Mini International Neuropsychiatric Interview (MINI) Version 5.0
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The goal of this project is to develop and test a brief protocol designed to systematically integrate pharmacological interventions for Attention Deficit Hyperactivity Disorder (ADHD) into behavioral treatment services for adolescent substance users with co-morbid ADHD in everyday care. Primary study aims will yield proof-of-concept data on MIP feasibility and fidelity in usual care and evidence of MIP impact on psychiatric and behavioral services utilization, medication acceptance and compliance, and satisfaction with treatment services.

Registry
clinicaltrials.gov
Start Date
November 2011
End Date
December 2014
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
The National Center on Addiction and Substance Abuse at Columbia University
Responsible Party
Principal Investigator
Principal Investigator

Aaron Hogue

Director of Adolescent & Family Research

The National Center on Addiction and Substance Abuse at Columbia University

Eligibility Criteria

Inclusion Criteria

  • Age 13-17 years
  • Caregiver able to participate in treatment
  • One day of alcohol use to intoxication or illegal drug use in the past 30 days (or 30 days prior to living in a controlled environment)
  • endorsement of one or more DSM-IV symptoms of Substance Use or Alcohol Dependence/Abuse
  • meet ASAM criteria for outpatient substance use treatment
  • meet DSM-IV criteria for ADHD (with or without onset prior to age 7)
  • not enrolled in any behavioral treatment

Exclusion Criteria

  • Bipolar Disorder
  • Mental Retardation
  • medical or psychiatric illness requiring hospitalization
  • current psychotic features
  • currently suicidal

Outcomes

Primary Outcomes

Mini International Neuropsychiatric Interview (MINI) Version 5.0

Time Frame: Follow-up in 3 months

MINI is a structured diagnostic interview that assesses DSM-IV diagnoses in adolescents and is designed for administration by lay interviewers. Adolescents and caregivers will complete the Inattentive and Hyperactive/Impulsive scales.

Secondary Outcomes

  • Behavior Rating Inventory of Executive Function (BRIEF)(Follow-up at 3-months)

Study Sites (1)

Loading locations...

Similar Trials